Next Article in Journal
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action
Next Article in Special Issue
Building Cell Selectivity into CPP-Mediated Strategies
Previous Article in Journal
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Previous Article in Special Issue
Imperatoxin A, a Cell-Penetrating Peptide from Scorpion Venom, as a Probe of Ca2+-Release Channels/Ryanodine Receptors
Pharmaceuticals 2010, 3(4), 1232-1240; doi:10.3390/ph3041232

Notes on Article Versions

article xml file uploaded5 June 2014 08:57 CEST
article html file updated5 June 2014 08:57 CEST
article html file updated16 June 2015 09:30 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert